Skip to main content
BIOGEN PHARMACHEM INDUSTRIES LIMITED logo

BIOGEN PHARMACHEM INDUSTRIES LIMITED — Investor Relations & Filings

Ticker · 531752 ISIN · INE703D01023 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 531752

About BIOGEN PHARMACHEM INDUSTRIES LIMITED

https://www.biogenpharma.bar/

Biogen Pharmachem Industries Limited specializes in the trading and distribution of chemical products, pharmaceutical raw materials, and intermediates. The company facilitates the procurement and supply of a broad portfolio of specialty chemicals and active ingredients required for various industrial applications. Its core operations involve managing supply chain logistics to provide manufacturers with essential components for production processes. By maintaining a network of suppliers and focusing on technical compliance, the company serves as an intermediary in the sourcing of industrial-grade chemicals and pharmaceutical components. The business model emphasizes reliability in the distribution of raw materials to support the manufacturing requirements of its diverse client base.

Recent filings

Filing Released Lang Actions
PFA
Regulatory Filings Classification · 90% confidence The document is an independent Annual Secretarial Compliance Report issued by a Practicing Company Secretary in compliance with SEBI LODR Regulations. It provides certification on regulatory and secretarial compliance rather than substantive financial statements or management commentary. It is therefore a compliance certification or officer attestation, which falls under general regulatory filings. According to the Certification Rule and the fallback for compliance certificates, this should be classified as a Regulatory Filing (RNS).
2026-05-23 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd
Major Shareholding Notification Classification · 98% confidence The document is a formal disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, providing before-and-after shareholding details for Rama Shiva Lease Finance Private Limited’s acquisition in Biogen Pharmachem Industries Limited. This is a notification of a change in significant share ownership. It clearly matches the Major Shareholding Notification category.
2026-05-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd
Major Shareholding Notification Classification · 90% confidence The document is a formal disclosure under SEBI Regulation 29(2) concerning the acquisition and sale of shares of Biogen Pharmachem Industries, detailing shareholding before and after the transaction. This exactly matches a notification of changes in significant share ownership levels. Therefore, it should be classified as a Major Shareholding Notification (MRQ).
2026-05-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parichay Infrastructure Ltd
Major Shareholding Notification Classification · 96% confidence The document is a formal disclosure submitted to the stock exchange under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, detailing the acquisition of shares by Parichay Infrastructure Limited and showing shareholding levels before and after the transaction. This is a regulatory notification of a major shareholding change, matching the ‘Major Shareholding Notification’ category.
2026-05-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Interface Financial Services Ltd
Major Shareholding Notification Classification · 90% confidence The document is a statutory disclosure made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, detailing pre- and post-transaction shareholdings, mode and date of acquisition, etc. This fits precisely within the definition of a Major Shareholding Notification (MRQ).
2026-05-19 English
PFA
Share Issue/Capital Change Classification · 87% confidence The document is a stock exchange filing under SEBI LODR Regulation 30 announcing the allotment of 15,04,33,833 bonus equity shares and the resultant increase in issued and paid-up capital. This is a clear announcement of a share issue/capital change rather than a report or financial statements. Therefore it maps to Share Issue/Capital Change (Code: SHA).
2026-05-18 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.